Innate Pharma S.A.
IPHYF
$1.50
$0.139.29%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 40.28M | 40.26M | 70.50M | 64.88M | 83.62M |
| Total Receivables | 8.94M | 8.93M | 1.41M | 1.30M | 1.70M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.80M | 2.80M | 2.53M | 2.32M | 2.92M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.82M | 2.82M | 1.87M | 1.73M | 527.00K |
| Total Current Assets | 54.84M | 54.80M | 76.31M | 70.23M | 88.77M |
|
|
|||||
| Total Current Assets | 54.84M | 54.80M | 76.31M | 70.23M | 88.77M |
| Net Property, Plant & Equipment | 5.11M | 5.11M | 5.82M | 5.36M | 5.31M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.41M | 1.41M | 14.81M | 13.63M | 10.25M |
| Total Assets | 73.64M | 73.59M | 109.15M | 100.45M | 114.98M |
|
|
|||||
| Total Accounts Payable | 8.78M | 8.77M | 5.34M | 4.92M | 8.20M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.33M | 10.33M | 10.49M | 9.66M | 9.02M |
| Total Finance Division Other Current Liabilities | 23.92M | 23.90M | 18.72M | 17.23M | 16.93M |
| Total Other Current Liabilities | 23.92M | 23.90M | 18.72M | 17.23M | 16.93M |
| Total Current Liabilities | 43.03M | 43.00M | 34.56M | 31.81M | 34.15M |
|
|
|||||
| Total Current Liabilities | 43.03M | 43.00M | 34.56M | 31.81M | 34.15M |
| Long-Term Debt | 16.05M | 16.04M | 21.07M | 19.39M | 22.97M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 113.90K | 113.80K | 177.30K | 163.20K | 107.70K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 39.92M | 39.90M | 47.30M | 43.53M | 48.61M |
| Total Liabilities | 99.12M | 99.05M | 103.10M | 94.89M | 105.83M |
|
|
|||||
| Common Stock & APIC | 484.58M | 484.24M | 483.45M | 444.94M | 409.12M |
| Retained Earnings | -511.38M | -511.02M | -478.81M | -440.67M | -400.00M |
| Treasury Stock & Other | 1.31M | 1.31M | 1.40M | 1.29M | 28.00K |
| Total Common Equity | -25.48M | -25.47M | 6.04M | 5.56M | 9.15M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -25.48M | -25.47M | 6.04M | 5.56M | 9.15M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -25.48M | -25.47M | 6.04M | 5.56M | 9.15M |
|
|
|||||